Status:
COMPLETED
Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Chronic Liver Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Histopathological examination of liver tissue is used to determine the etiology and extent of liver disease. In order for a clinician to make a better-informed decision regarding a patient with liver ...
Detailed Description
Date: 01/03/2019 Version Number: 1 Principal Investigator: Ghassan Hammoud MD Application Number: 2011629 Application Title: Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies versus Perc...
Eligibility Criteria
Inclusion
- all patients ≥ 18 years of age
- subjects undergoing a liver biopsy for focal/diffuse abnormalities of the liver
- parenchymal disease or chronically elevated liver function tests
- for assessing degree of fibrosis in chronic liver diseases
- or any indication deemed as necessary per the hepatologist/physician
Exclusion
- Age \<18
- Coagulopathy (INR of ≥1.5 and/or platelet count ≤ 50,000)
- Use of anticoagulants and/or blood thinners within 24 hours before the planned procedure
- Liver lesions such as hemangioma, echinococcal cyst or vascular tumors,
- Pregnancy,
- Uncooperative patients
- Any other condition or abnormalities that, in the opinion of the referring hepatologist or the advanced endoscopist, may compromise the safety of the patient or interfere with the patient participating in or completing the study.
Key Trial Info
Start Date :
October 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04751045
Start Date
October 25 2020
End Date
October 1 2021
Last Update
December 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Hospital
Columbia, Missouri, United States, 65212